⌘K
Independent Capital
Deals on record
1
Common Fundraising Type
Seed
Autoimmunity BioSolutions
Biotechnology • Immuno-corrective therapies
Autoimmunity BioSolutions develops next-generation immuno-corrective therapies targeting genetically-defined subpopulations of patients with autoimmune diseases.